Overhaul could cut UK brand prices 20%
This article was originally published in Scrip
Executive Summary
Prices of branded medicines used in the UK could undergo cuts of between 10% and 20%, according to a government consultation on proposals for changing the pricing of drugs used on the National Health Service.
You may also be interested in...
Italy To Consult On Pricing Transparency Requirements
Draft guidelines due out for consultation this week in Italy are expected to shed more light on what companies will have to reveal during pricing and reimbursement negotiations.
German Guidelines Seek To Boost Biosimilar Uptake
Germany is for the first time to adopt national guidelines on prescribing biologics and biosimilars in a move towards increasing biosimilar uptake.
European Regulatory Strategy ‘Should Prioritize Real World Evidence’
EFPIA, the European Federation of Pharmaceutical Industries and Associations, has put forward what it thinks the European regulatory network strategy to 2025 should prioritize.
Need a specific report? 1000+ reports available
Buy Reports